- Home
- IKT vs ORMP Comparison
IKT vs ORMP Comparison
Compare IKT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- ORMP
- Stock Information
- Founded
- IKT 2008
- ORMP 2002
- Country
- IKT United States
- ORMP United States
- Employees
- IKT N/A
- ORMP N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- IKT Health Care
- ORMP Health Care
- Exchange
- IKT Nasdaq
- ORMP Nasdaq
- Market Cap
- IKT 123.7M
- ORMP 104.6M
- IPO Year
- IKT 2020
- ORMP N/A
- Fundamental
- Price
- IKT $1.63
- ORMP $2.43
- Analyst Decision
- IKT Buy
- ORMP
- Analyst Count
- IKT 2
- ORMP 0
- Target Price
- IKT $8.00
- ORMP N/A
- AVG Volume (30 Days)
- IKT 138.4K
- ORMP 122.1K
- Earning Date
- IKT 11-13-2025
- ORMP 11-06-2025
- Dividend Yield
- IKT N/A
- ORMP N/A
- EPS Growth
- IKT N/A
- ORMP N/A
- EPS
- IKT N/A
- ORMP N/A
- Revenue
- IKT N/A
- ORMP $2,000,000.00
- Revenue This Year
- IKT N/A
- ORMP N/A
- Revenue Next Year
- IKT N/A
- ORMP N/A
- P/E Ratio
- IKT N/A
- ORMP N/A
- Revenue Growth
- IKT N/A
- ORMP N/A
- 52 Week Low
- IKT $1.15
- ORMP $1.82
- 52 Week High
- IKT $4.20
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- IKT 48.84
- ORMP 54.47
- Support Level
- IKT $1.57
- ORMP $2.37
- Resistance Level
- IKT $1.70
- ORMP $2.57
- Average True Range (ATR)
- IKT 0.12
- ORMP 0.15
- MACD
- IKT 0.01
- ORMP -0.01
- Stochastic Oscillator
- IKT 51.61
- ORMP 39.58
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.